Amgen Inc.
Amgen Inc.
3
Total Publications
2
Abstract/Manuscript
1
Oral Presentation
2021 · Abstract/Manuscript · Amgen Inc.
Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice
Read more →2020 · Abstract/Manuscript · Amgen Inc.
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
Read more →2018 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi